Table 1 Basic characteristics of the study population
Characteristic | Epoprostenol | Placebo | |
|---|---|---|---|
Age, median (range) | 29 (15–63) | 34 (16–63) | ns |
Gender, F/M, n | 10/13 | 7/16 | ns |
APACHE II, median (range) | 20 (12–29) | 21 (14–32) | ns |
GCS, median (range) | 5 (3–8) | 6 (3–8) | ns |
ISS, median (range) | 29 (9–50) | 29 (9–43) | ns |
AIS Head, median (range) | 5 (3–5) | 4 (3–5) | ns |
Multi-trauma, n (%) | 17/23 (74) | 14/23 (61) | ns |
Antibiotic treatment, n (%) | 22/23 (96) | 21/23 (91) | ns |
Surgery, n (%) | 17/23 (74) | 19/23 (79) | ns |
Time from accident to start of study infusion in minutes (mean ± SD) | 1131 ± 345 | 987 ± 310 | ns |